These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 28411843)

  • 1. The Molecular Revolution in Cutaneous Biology: Emerging Landscape in Genomic Dermatology: New Mechanistic Ideas, Gene Editing, and Therapeutic Breakthroughs.
    Titeux M; Izmiryan A; Hovnanian A
    J Invest Dermatol; 2017 May; 137(5):e123-e129. PubMed ID: 28411843
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Montagna Symposium 2017-Precision Dermatology: Next Generation Prevention, Diagnosis, and Treatment.
    Tolar J; Bauer JW; Kaplan DH; Leachman SA; McGrath JA; Paller AS; Griffith-Bauer KA; Stemwedel CE; Kulesz-Martin MF
    J Invest Dermatol; 2018 Jun; 138(6):1243-1248. PubMed ID: 29550416
    [No Abstract]   [Full Text] [Related]  

  • 3. Integrating functional genomics to accelerate mechanistic personalized medicine.
    Tyner JW
    Cold Spring Harb Mol Case Stud; 2017 Mar; 3(2):a001370. PubMed ID: 28299357
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Machine learning for precision dermatology: Advances, opportunities, and outlook.
    Lee EY; Maloney NJ; Cheng K; Bach DQ
    J Am Acad Dermatol; 2021 May; 84(5):1458-1459. PubMed ID: 32645400
    [No Abstract]   [Full Text] [Related]  

  • 5. Computational drug repositioning for rare diseases in the era of precision medicine.
    Delavan B; Roberts R; Huang R; Bao W; Tong W; Liu Z
    Drug Discov Today; 2018 Feb; 23(2):382-394. PubMed ID: 29055182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Personalizing dermatology: the future of genomic expression profiling to individualize dermatologic therapy.
    Rizzo AE; Maibach HI
    J Dermatolog Treat; 2012 Jun; 23(3):161-7. PubMed ID: 21254882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. From molecules to medicines: the dawn of targeted therapies for genetic epilepsies.
    Demarest ST; Brooks-Kayal A
    Nat Rev Neurol; 2018 Dec; 14(12):735-745. PubMed ID: 30448857
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficient in vivo gene editing using ribonucleoproteins in skin stem cells of recessive dystrophic epidermolysis bullosa mouse model.
    Wu W; Lu Z; Li F; Wang W; Qian N; Duan J; Zhang Y; Wang F; Chen T
    Proc Natl Acad Sci U S A; 2017 Feb; 114(7):1660-1665. PubMed ID: 28137859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine.
    Paolillo C; Londin E; Fortina P
    Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic Analysis of Childhood Brain Tumors: Methods for Genome-Wide Discovery and Precision Medicine Become Mainstream.
    Mack SC; Northcott PA
    J Clin Oncol; 2017 Jul; 35(21):2346-2354. PubMed ID: 28640705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular therapies for inherited epidermolysis bullosa.
    Has C
    G Ital Dermatol Venereol; 2016 Aug; 151(4):397-402. PubMed ID: 27149615
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Molecular dermatology comes of age.
    Has C; Sitaru C
    Methods Mol Biol; 2013; 961():1-16. PubMed ID: 23325634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of next generation sequencing on diagnostics in a genetic skin disease clinic.
    Takeichi T; Nanda A; Liu L; Salam A; Campbell P; Fong K; Akiyama M; Ozoemena L; Stone KL; Al-Ajmi H; Simpson MA; McGrath JA
    Exp Dermatol; 2013 Dec; 22(12):825-31. PubMed ID: 24279917
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Opportunities and technical challenges in next-generation sequencing for diagnosis of rare pediatric diseases.
    Bacchelli C; Williams HJ
    Expert Rev Mol Diagn; 2016 Oct; 16(10):1073-1082. PubMed ID: 27560481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks.
    Lin S; Yin YA; Jiang X; Sahni N; Yi S
    Biomed Res Int; 2016; 2016():6186281. PubMed ID: 27403431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exome sequencing a review of new strategies for rare genomic disease research.
    Brown TL; Meloche TM
    Genomics; 2016 Oct; 108(3-4):109-114. PubMed ID: 27387609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genomic medicine and risk prediction across the disease spectrum.
    Kotze MJ; Lückhoff HK; Peeters AV; Baatjes K; Schoeman M; van der Merwe L; Grant KA; Fisher LR; van der Merwe N; Pretorius J; van Velden DP; Myburgh EJ; Pienaar FM; van Rensburg SJ; Yako YY; September AV; Moremi KE; Cronje FJ; Tiffin N; Bouwens CS; Bezuidenhout J; Apffelstaedt JP; Hough FS; Erasmus RT; Schneider JW
    Crit Rev Clin Lab Sci; 2015; 52(3):120-37. PubMed ID: 25597499
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic approaches to diagnose rare bone disorders.
    Falardeau F; Camurri MV; Campeau PM
    Bone; 2017 Sep; 102():5-14. PubMed ID: 27474525
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome Editing Techniques and Their Therapeutic Applications.
    Calos MP
    Clin Pharmacol Ther; 2017 Jan; 101(1):42-51. PubMed ID: 27783398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Targeted Therapies Based on Gene Modification.
    Benson TM; Leti F; DiStefano JK
    Methods Mol Biol; 2018; 1706():39-51. PubMed ID: 29423792
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.